We are excited to partner with SuanNutra.
Carbyne Equity Partners (“Carbyne”) is pleased to announce the acquisition of SuanNutra, the nutraceutical ingredients business of Suanfarma, a portfolio company of ARCHIMED. The investment, marks Carbyne’s entry into the nutraceutical sector and aligns with its focus on building R&D-driven businesses alongside strong management teams. We are excited about meaningful opportunities ahead – whether through securing dedicated supply chains, broadening its portfolio of clinically validated ingredients or deepening its relevance among an already diverse customer base.
